Clinical Trials Resource Center
Search

Clinical Trial Services
Protocol Development
Consent Development
Recruitment Strategy
Budgeting
Data & Safety Monitoring
Safety Reporting
Quality Management
Study Management
 
Clinical Trial Services
li
IND / IDE Submissions
li
ClinicalTrials.Gov Registration
FDA Inspection
Validation and Compliance with 21 CFR Part 11
Clinical Trial Services
li
Mission, Vision and Goals
li
Staff
li
Home
Visit the Center for Clinical & Translational Sciences


Clinical Trial Services
Investigators
Study Staff
Partners
Participants
 
Clinical Trial Services
Clinical Trial Budgeting
Clinical Research Coordinator Course
Good Clinical Practice Training
UT Health Investigator Courses
Clinical Research Forum
Human Subjects Training
li
iRIS Training

Clinical Trial Services
li
Policies
li
Federal Regulations
li
Human Subjects Protection Program
li
ICH GCP Guidelines
li
Newsletter
li
*Quick Reference*
|| IQ BOX ||


 

CLINICAL TRIAL CONSENT DEVELOPMENT

CONSENT DEVELOPMENT

Consent Writing Tools and Guidance

PRISM Readability Toolkit
Online Readability Tool (insert your wording for readability statistics)
PlainLanguage.gov (glossary of simplified words)
Web Based Instruction on Informed Consent (UofMinn)
NIH Guidance
Resources for Writing Non-English Consent Forms

The UTHSC-H policies require that written informed consent be obtained from all human subjects prior to their participation in any research unless the requirement has been waived by CPHS.The language of the consent document should be in the second person style such that it conveys a dialogue with information being provided and that there is a choice to be made by the subject rather than presumption of the subject’s consent with the use of the first person style.  The information provided in the consent document should be simple enough that a subject at 6th to 8th grade reading level can understand it. Technical and scientific terms should be adequately explained using simple language.
Consent documents should not contain any exculpatory language through which the subject is made to waive or appear to waive legal rights, or releases or appears to release the Investigator, the Sponsor, or the institution from liability for negligence.

Many investigators find that starting with the CPHS Consent Template is very helpful. If you need help with developing a consent document, please feel free to contact us.

For additional guidance on informed consent process, please refer to CPHS policy and Investigator Handbook.

 


Your Portal to Best Practices in Clinical Trial Management
EMAIL: CLINICALTRIALS@UTH.TMC.EDU PHONE: 713-500-3622 FAX 713-500-0334
University of Texas Houston Health Science Center Logo